Medicare Enrolled

Dr. Doron Weiner, MD

Hematology & Oncology · Rockville Centre, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
242 MERRICK RD, Rockville Centre, NY 11570
5165361455
In practice since 2007 (19 years)
NPI: 1881751634 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Weiner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weiner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Weiner

Dr. Doron Weiner is a hematology & oncology specialist in Rockville Centre, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Weiner performed 46,547 Medicare services across 1,647 unique beneficiaries.

Between the years covered by Open Payments, Dr. Weiner received a total of $5,517 from 36 pharmaceutical and/or device companies across 247 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Weiner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 14% volume in NY $5,517 industry payments

Medicare Practice Summary

Medicare Utilization ↗
46,547
Medicare services
Top 14% in NY for hematology & oncology
1,647
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,450 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Darbepoetin injection (Aranesp) for anemia
An injection of darbepoetin alfa used for non-end-stage renal disease purposes.
36,400 $2 $8
Denosumab injection (Prolia/Xgeva) 5,640 $19 $38
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
1,360 $8 $25
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,160 $8 $20
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
741 $115 $350
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
405 $76 $250
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
332 $13 $50
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
158 $72 $275
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
93 $4 $15
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
58 $141 $450
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
50 $1 $4
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
49 $118 $500
Venipuncture for blood collection
A procedure to draw blood from a vein for medical testing or analysis.
41 $86 $380
Irrigation of implanted venous access device
This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids.
24 $25 $105
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
14 $170 $915
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
11 $147 $725
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
11 $103 $385
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,517
Total received (2018-2024)
Avg $788/year across 7 years
Top 33% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
247
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,322 (78.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$896 (16.2%)
Other
Charitable contributions, space rental, and other categories
$299 (5.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$408
2023
$867
2022
$731
2021
$700
2020
$342
2019
$1,266
2018
$1,202

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$171
Incyte Corporation
$85
E.R. Squibb & Sons, L.L.C.
$36
GENZYME CORPORATION
$33
PFIZER INC.
$29
Daiichi Sankyo Inc.
$26
Myriad Genetic Laboratories, Inc.
$15
Menarini Silicon Biosystems, Inc.
$14
Top 3 companies account for 71.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,704
E.R. Squibb & Sons, L.L.C.
$802
Incyte Corporation
$398
PFIZER INC.
$367
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Genentech USA, Inc.
$279
Janssen Biotech, Inc.
$198
Merck Sharp & Dohme Corporation
$167
Astellas Pharma US Inc
$165
Alexion Pharmaceuticals, Inc.
$123
Janssen Products, LP
$100
Amgen Inc.
$97
Clovis Oncology, Inc.
$76
GENZYME CORPORATION
$69
Ipsen Biopharmaceuticals, Inc
$69
EMD Serono, Inc.
$68
Seagen Inc.
$58
Pharmacyclics LLC, An AbbVie Company
$52
Celgene Corporation
$46
Array BioPharma Inc.
$43
Myovant Sciences Inc.
$39
Daiichi Sankyo Inc.
$39
GlaxoSmithKline, LLC.
$25
CTI BioPharma Corp.
$25
AstraZeneca Pharmaceuticals LP
$23
Organon LLC
$22
EISAI INC.
$21
Lilly USA, LLC
$21
AMAG Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme LLC
$19
Aveo Pharmaceuticals, Inc.
$18
Myriad Genetic Laboratories, Inc.
$15
Menarini Silicon Biosystems, Inc.
$14
Blueprint Medicines Corporation
$14
Gilead Sciences, Inc.
$12
Exelixis Inc.
$11
Top 3 companies account for 52.6% of all-time payments
Associated products mentioned in payments ›
AYVAKIT · Abraxane · Avastin · BLENREP · Bavencio · Braftovi · CABLIVI · CALQUENCE · Cabometyx · Cellsearch · ELIQUIS · EMPLICITI · Erleada · FERAHEME · FOTIVDA · IBRANCE · IMBRUVICA · INFLECTRA · Imbruvica · JADENU · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LUTATHERA · Lenvima · MEKINIST · MYRISK · Neulasta · ONTRUZANT · OPDIVO · ORGOVYX · OXBRYTA · PADCEV · PIQRAY · PROMACTA · Perjeta · REBLOZYL · RYDAPT · Rubraca · SCEMBLIX · SOLIRIS · TASIGNA · TECENTRIQ · Tazverik · Tecentriq · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Vonjo · XALKORI · XOSPATA · XTANDI · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Rockville Centre?
Compare hematology & oncology specialists in the Rockville Centre area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
630
Per 100K population
45.4
County median income
$143,408
Nearest hospital
MOUNT SINAI SOUTH NASSAU
2.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Weiner is a mixed practice specialist, with above-average Medicare volume (top 14% in NY), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Weiner experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Weiner performed 36,400 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Weiner receive payments from pharmaceutical companies?
Yes. Dr. Weiner received a total of $5,517 from 36 companies across 247 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weiner's costs compare to other hematology & oncology specialists in Rockville Centre?
Dr. Weiner's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weiner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →